Iowa HF183 allows pharmacists to order and administer HIV-related tests and prophylaxis drugs, and mandates health benefit plans to reimburse these.
Iowa HF183 expands the role of pharmacists in HIV care by allowing them to order and administer point-of-care HIV-related tests and prophylaxis drugs, such as pre-exposure and post-exposure prophylaxis. The bill mandates that health benefit plans provide payment or reimbursement for these services if they are within the lawful scope of practice for pharmacists. This change is intended to improve access to HIV-related care and treatment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.